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Introduction
Several studies have reported increased cardiac events
and mortality during the winter months.1–3 The
metabolic syndrome refers to a cluster of metabolic
abnormalities, including hypertriglyceridemia, low
high-density lipoprotein cholesterol (HDL-C), glu-
cose intolerance, central obesity, and hypertension.
These metabolic abnormalities are also known cardio-
vascular disease risk factors,4 and the most accepted
and unifying hypothesis to describe the pathophysiol-
ogy of the metabolic syndrome is insulin resistance.5
There are few reports6 regarding the association
between seasonal variation and the metabolic syn-
drome, but there are several studies7–14 on the effects
of season on insulin. Inconsistent findings were noted
in these studies. Insulin resistance and triglyceride
levels were higher during the summer in some stud-
ies,7,8 while another study showed higher levels in
winter than in summer,9 and several studies showed
no significant seasonal variation.10–14 In previous
work,6 we found that the prevalence of metabolic
syndrome in women was higher in the summer than
in the winter (30.9% vs. 27.6%), but fasting insulin
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was checked only in Kin-Chen, a town in Kinmen
county.
Kinmen (Quemoy) lies 2,310 m (< 1.5 miles) away
from the southern mainland of China and is located
at a latitude of approximately 24°C north.15 It has a
subtropical climate which shows seasonal variations 
in temperature (winter: 9.8–14.3°C, with a mean of
11.8°C; summer: 25–33°C, with a mean of 27°C). 
A series of topics including diabetes, hypertension and
coronary heart disease has been studied.16–18 The pur-
pose of this study was to explore the summer-winter
difference in insulin sensitivity, insulin resistance and
its risk factors in Kin-Chen, Kinmen.
Methods
Study sample
The characteristics of the target population and the
methods used in the series of Kinmen studies have been
previously reported.16–18 This study focused on those
residents over 40 years old in Kin-Chen, the largest
township in Kinmen.16–18 They were studied in differ-
ent villages during winter (January and February, before
Chinese New Year) and summer (July and August) in
2002. A total of 4,545 residents were eligible for screen-
ing and were surveyed by the Yang-Ming Crusade, 
a volunteer organization of well-trained medical stu-
dents from National Yang-Ming University.16–18 Demo-
graphic and clinical parameters including body height,
body weight, body mass index (BMI, weight/height2),
waist-to-hip ratio, systolic and diastolic blood pressures
were acquired with face-to-face interviews and struc-
tured questionnaires. Ethics approval was obtained
from the Yu-Li Veterans Hospital Ethics Committee,
and all subjects gave written informed consent.
Definitions of variables
Blood samples were obtained after overnight fasting
for determination of plasma glucose, serum uric acid,
lipid, and other biochemical measurements, as was
previously reported.16–18 Fasting plasma glucose was
determined using the hexokinase-glucose-6-phosphate
dehydrogenase method using a glucose (HK) reagent
kit (Gilford, Oberlin, OH, USA). Waist girth was mea-
sured at the minimum circumference. Serum insulin
was measured by radioimmunoassay (Incstar, Stillwater,
OH, USA). The detection limit was 2.05 μU/mL. The
intra- and interassay coefficients of variation were 7.4%
and 9.1%, respectively. “Frequent” physical activity was
defined as exercise > 1 time/week or high daily activity
(including work); all others were categorized as “infre-
quent”. Three consecutive blood pressure readings,
separated by at least 5 minutes, were taken from the
right arm from seated subjects. According to the Third
Report of the National Cholesterol Education Pro-
gram Expert Panel on Detection, Evaluation, and Treat-
ment of High Blood Cholesterol in Adults (ATP III)
criteria4 and the revised definition according to Asia-
Pacific criteria for abdominal obesity,19 the definition of
metabolic syndrome is defined as having 3 or more of
the following 5 criteria: high blood pressure (systolic
blood pressure ≥130mmHg or diastolic blood pressure
≥ 85 mmHg); high fasting plasma glucose (≥ 110 mg/
dL [6.05 mmol/L]); abdominal obesity (waist circum-
ference > 90 cm in men and > 80 cm in women); hyper-
triglyceridemia (≥ 150 mg/dL [1.65 mmol/L]); low
HDL-C (< 40 mg/dL [1.05 mmol/L] in men and
< 50 mg/dL [1.30 mmol/L] in women).
We used the homeostasis model assessment
(HOMA-IR) model to estimate the levels of insulin
resistance in the population.20 The estimate of insulin
resistance obtained by HOMA-IR correlated with
estimates obtained by use of the euglycemic clamp
(r = 0.88, p < 0.0001).20 The formula of the HOMA-
IR model is as follows:21
[Fasting insulin (μU/mL)
× fasting glucose (mmol/L)]/22.5
Statistical analysis
All statistical analyses were performed using the SAS
statistical package (SAS Inc., Cary, NC, USA). Data are
presented as means and standard deviations for con-
tinuous variables and proportions for categorical vari-
ables. Two-sample t test and the χ2 test were used in
univariate analysis. To analyze the independent effect
of summer-winter difference, multiple logistic regres-
sion (for the metabolic syndrome) and multiple linear
regression (for log fasting insulin and log HOMA-IR)
as a function of covariates, including age, gender,
BMI, lifestyle and other risk profiles were assessed. 
A stepwise procedure was applied to do model selection.
Results
At the beginning of the study in 2000, 4,545 residents
(2,296 men and 2,249 women) were eligible for screen-
ing, and a total of 2,412 residents participated in the
study during 2000 to 2003. The overall response rate
was 53.1%. After excluding those with missing data,
2,175 subjects with complete blood data and completed
questionnaires were available for analysis.
Table 1 shows the demographic and lifestyle char-
acteristics of the study subjects. Analysis revealed that
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1,492 subjects (68.6%) participated in the winter, and
683 subjects (31.4%) participated in the summer. Their
mean age was 55.4 years (range, 40–89 years). The
women who participated in winter were of an older
age than those who participated in summer. The levels
of triglycerides, fasting insulin and HOMA-IR were
higher in summer than in winter, while cholesterol level
was higher in winter than in summer for both genders.
Waist-to-hip ratio, BMI, waist circumference, and uric
acid had no significant summer-winter difference in
both genders. The levels of systolic blood pressure, dias-
tolic blood pressure, HDL-C and fasting plasma glucose
were all higher in winter than in summer, particularly
in women. On the other hand, the prevalence of hyper-
triglyceridemia, low HDL-C and metabolic syndrome
were higher in summer than in winter, but high fast-
ing plasma glucose was higher in winter than in sum-
mer in both genders. High blood pressure was higher
in winter than in summer, particularly in women.
There was no significant difference in the prevalence
of abdominal obesity between summer and winter in
both genders. Men engaged in less frequent physical
activity in winter than in summer. The prevalence of
smoking and alcohol drinking were not significantly
different between summer and winter in both genders.
We found no prominent significant association between
menopause and season in women.
Table 2 presents the results of multiple logistic
regression models for metabolic syndrome. For both
genders, the winter season was negatively associated
with metabolic syndrome. In contrast, the signifi-
cantly protective effect of frequent physical activity for
metabolic syndrome was only found in men, not in
women. Frequent physical activity had no longer pro-
tective effect versus metabolic syndrome in the strati-
fied analysis by gender. BMI and age were
significantly correlated with metabolic syndrome in
both summer and winter. Menopause was a signifi-
cant risk factor for metabolic syndrome in women.
To control confounding effects, Table 3 presents
the results of multiple linear regression models for 
log HOMA-IR, log fasting insulin, and stratified by
metabolic syndrome, controlling for season, gender,
biochemistry and other confounders. In participants
without metabolic syndrome, the linear regression
model showed that BMI, mean blood pressure, triglyc-
erides and fasting plasma glucose were risk factors for
fasting insulin, while winter was significantly negatively
associated with fasting insulin. In participants with meta-
bolic syndrome, the linear regression model showed
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Table 2. Multiple logistic regression models on metabolic syndrome among residents aged ≥ 40 years stratified by season in Kin-Chen,
Kinmen, 2002
Outcome Metabolic syndrome
All Participants Participants in winter Participants in summer
Variables* OR 95% CI OR 95% CI OR 95% CI
All
Season (winter vs. summer) 0.51 0.38, 0.67
Age (yr) 1.05 1.04, 1.06 1.05 1.04, 1.06 1.05 1.03, 1.07
Gender (men vs. women) NS – NS – NS –
BMI (kg/m2) 1.46 1.40, 1.53 1.48 1.39, 1.57 1.43 1.33, 1.55
Physical activity (frequent vs. infrequent) 0.73 0.56, 0.95 0.66 0.47, 0.92 NS –
Men
Season (winter vs. summer) 0.57 0.38, 0.84
Age (yr) 1.03 1.02, 1.05 1.03 1.01, 1.06 1.03 1.00, 1.06
BMI (kg/m2) 1.45 1.35, 1.56 1.46 1.33, 1.59 1.42 1.27, 1.59
Physical activity (frequent vs. infrequent) 0.67 0.46, 0.97 NS – NS –
Women
Season (winter vs. summer) 0.47 0.32, 0.71
Age (yr) 1.05 1.03, 1.08 1.04 1.02, 1.07 1.08 1.05, 1.12
BMI (kg/m2) 1.46 1.37, 1.56 1.48 1.36, 1.60 1.44 1.28, 1.61
Physical activity (frequent vs. infrequent) NS – 0.59 0.36, 0.96 NS –
Menopause (yes vs. no) 2.17 1.23, 3.84 2.77 1.30, 5.88 NS –
*Other variables of education, alcohol drinking, smoking, fish, seafood, meat and visceral food were not significant. OR = odds ratio; CI = confidence interval;
BMI = body mass index; NS = not significant.
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that BMI, uric acid and fasting plasma glucose were
risk factors for fasting insulin, while winter, HDL-C
and smoking were significantly negatively associated
with fasting insulin. In all participants, BMI was the
most important predictor for fasting insulin and ex-
plained 10–19% of the variance of fasting insulin. Sea-
sonal effect was the second predictor for fasting insulin
and explained 4% of the variance of fasting insulin.
Fasting glucose and triglycerides explained 1–3% of the
variance of fasting insulin. Mean blood pressure, cho-
lesterol, HDL-C, smoking, alcohol drinking and phys-
ical activity explained less than 1% of the variance of
fasting insulin. Table 3 also presents the same results
of multiple linear regression models in all participants
for log HOMA-IR; the most important predictor was
fasting plasma glucose, which explained 36.1% of the
variance of fasting insulin.
Discussion
The findings from this large-scale, homogeneous Chi-
nese population revealed a higher prevalence of meta-
bolic syndrome in summer than in winter. The results
also indicated that summer was positively associated
with fasting insulin and insulin resistance. On the other
hand, BMI and season were 2 major determinants of
the variation in fasting insulin. Fasting glucose, BMI
and season were the 3 major determinants of the vari-
ation in HOMA-IR.
The seasonal variation in metabolic syndrome and
insulin resistance may reflect seasonal patterns in obe-
sity, diet and/or exercise,5,22,23 and the duration of
sunlight24 or intrinsic biologic rhythms.22,23 The
dietary intake has been linked to individual components
of metabolic syndrome25 and dietary intakes rich in
whole-grain foods have been linked to a lower preva-
lence of metabolic syndrome.26
There are no consistent results on the seasonal vari-
ation of fasting insulin as shown in Table 4.7–14 The
present study showed higher mean values of fasting
insulin and insulin resistance in summer than in winter,
and were consistent with a study in Chile.7 The most
plausible explanations for a seasonal variation in insulin
sensitivity could be the cyclical changes in body com-
position that have been previously described27 or mod-
ifications in the dietary intake due to the changing
availability of certain food items.
Recent studies have assessed and shown that appli-
cation of the ATP III metabolic syndrome criteria
provides good specificity but low sensitivity in the iden-
tification of subjects with insulin resistance.28–30 The
validity of the use of insulin as a surrogate for insulin
resistance remains to be established.31 This drawback
may partly explain the controversies about the rela-
tionship between insulin resistance/hyperinsulinemia
and the metabolic syndrome.32
The associations of BMI, age and physical activity
with metabolic syndrome and fasting insulin have been
established in previous studies.33–36 Aging is associ-
ated with glucose intolerance and insulin resistance,33
and consequently with an increased level of insulin. In
a logistic model, the significant age effect supported
previous research evidence.34
The importance of obesity as a risk factor for sev-
eral diseases, including type 2 diabetes and cardiovascu-
lar disease, is well documented.32 It has been reported
that body weight increases in winter, which is due to
more food intake, less physical activity, and greater use
of alcohol.37–39 Results from the current community-
based study were in agreement with those of previous
studies.37–39 A combination of weight loss and enhanced
physical activity may reduce the incidence of metabolic
syndrome.5
The relationship between blood pressure and insulin
resistance is well established, and relates to several dif-
ferent mechanisms.5,40,41 This study showed similar
results in all participants.
Season may have an impact on the quantity and type
of drinking. The mean number of drinks per week
reaches a maximum in late winter and a minimum in
summer.42 In Kinmen, more beer is consumed in sum-
mer than in winter, as a Korean study reported.42 Mild-
to-moderate alcohol consumption is associated with 
a lower prevalence of the metabolic syndrome, with 
a favorable influence on lipids, waist circumference, and
fasting insulin.43 But in this study, there was a higher
prevalence of the metabolic syndrome and insulin resis-
tance in the summer. This inverse result needs further
study. Similarly, chronic cigarette smokers have been
shown to be insulin-resistant and dyslipidemic.44 But
in our study, we found that smoking was negatively
associated with insulin. This issue also needs further
study.
The prevalence of the metabolic syndrome increases
with menopause and may partially explain the apparent
acceleration in cardiovascular disease after menopause.45
Menopause was found to be a significant risk factor
for metabolic syndrome in women in this study. We
found no significant association between HOMA-IR/
fasting insulin and menopause in women. After adding
menopause into the model, the seasonal effect on
HOMA-IR and fasting insulin remained more or less
the same.
Furthermore, BMI and season were 2 major de-
terminants of the variation in fasting insulin. It remains
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interesting that the causes of metabolic syndrome or
insulin resistance thus shifted from the environment
as a whole to specific factors within the environment
(biological mechanisms) and to the behaviors of indi-
viduals.46,47 Based on the epidemiologic point of view,
we therefore suggest that further studies are needed
to discuss the roles of macro-level for seasonal effect
and incorporate multiple level analysis technology in
shaping metabolic syndrome or insulin resistance in
populations.
Several possible limitations of this study should be
considered when interpreting the results. The cross-
sectional nature of the study limits the causal inter-
pretation of its findings. Future longitudinal studies
are needed to investigate the role of seasonal variation
in the pathogenesis of insulin resistance and metabolic
syndrome. Another limitation of this study is its lack
of information about patient use of lipid-lowering drugs,
which limits the interpretation of the seasonal differ-
ences of metabolic syndrome and insulin resistance.
In conclusion, insulin resistance, fasting insulin and
the prevalence of metabolic syndrome were higher in
summer than in winter. BMI and season were 2 major
determinants of the variance in fasting insulin and in-
sulin resistance, and were significantly associated with
metabolic syndrome. Based on the epidemiologic point
of view, the contextual impacts of seasonal variation in
shaping metabolic syndrome or insulin resistance in pop-
ulations need to be reemphasized. A combination of
weight loss and enhanced physical activity in summer
may reduce the prevalence of metabolic syndrome
and insulin resistance.
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